Status:
RECRUITING
Vitamin B6 Aids in Treating Inflammatory Bowel Disease
Lead Sponsor:
Changhai Hospital
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Patients with IBD are randomized to oral administration of VitaminB6 and placebo based on the standard treatment, exploring whether VitaminB6 can increasee the clinical remission rateand improve the t...
Detailed Description
Inflammatory bowel disease (IBD) is a group of chronic idiopathic inflammatory intestinal diseases, mainly including ulcerative colitis and Crohn's disease, with increasing incidence in China and worl...
Eligibility Criteria
Inclusion
- Patients diagnosed with IBD according to the consensus on the diagnosis and treatment of inflammatory bowel disease (Beijing, 2018, DOI: 10.19538/j.nk2018090106);
- Have complete medical history data;
- Volunteer to participate in this clinical trial and sign the informed consent form.
Exclusion
- Patients with peripheral neuropathy;
- Patients with abdominal abscess, toxic megacolon, fulminant colitis, partial colectomy, or total colectomy;
- Patients with other autoimmune diseases, hematologic disorders, tumors, acute infections, severe liver or kidney dysfunction, severe conditions such as severe anemia, neutropenia, heart failure, organic heart disease, hepatitis B, cirrhosis, kidney disease, and psychiatric disorders;
- Patients who have taken vitamin B6 tablets in the past 3 months;
- Patients with a history of substance abuse;
- Pregnant or lactating women, or those planning to become pregnant within the next 6 months;
- Neurological disorders such as Alzheimer's disease, stroke, Parkinson's disease;
- Participation in other clinical trials in the past 6 months;
- Incomplete medical records (including gender, age, diagnosis, colonoscopy results, pathological diagnosis results, and other demographic data);
- Currently taking: levodopa, phenobarbital, phenytoin sodium.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06512441
Start Date
June 1 2024
End Date
December 30 2025
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, Shanghai Municipality, China